July 25, 2024

Injection Port Market Is Expected To Be Flourished By Growing Adoption Of Pre-Filled Syringes

The injection port market is an integral part of the pharmaceutical packaging industry and is witnessing high demand from end-use industries such as pharmaceutical and biotechnology. Injection ports, also known as septa, enable filling processes in biopharmaceutical manufacturing and are made from materials such as silicone, PolyTetrafluoroEthylene (PTFE), etc. They provide a reliable seal and barrier that protect components inside drug containers from external contamination while allowing access to the contents using a needle or other instrument. With the burgeoning pharmaceutical industry and rising prevalence of diseases, manufacturers are increasingly utilizing pre-filled syringes for convenience and safety. This has boosted the adoption of injection ports as they play a vital role in packaging of pre-filled syringes.

The global Injection Port Market is estimated to be valued at Us$ 1.57 Bn in 2024 and is expected to exhibit a CAGR Of 7.6% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

Growing Adoption of Pre-Filled Syringes: As mentioned in the heading, pre-filled syringes provide convenience to patients and reduce dosing errors compared to conventional syringes. Their growing adoption across therapeutic areas like diabetes, oncology and arthritis is fueling the demand for injection ports. According to estimates, pre-filled syringe sales accounted for over 60% of the global injectable drug delivery market in 2021.

Stringent Safety and Sterility Requirements: Pharmaceutical packaging components including injection ports need to comply with stringent regulatory safety and sterility standards. They are subject to extensive testing and certification to prevent microbial contamination. This drives innovation and R&D among injection port manufacturers towards developing more reliable and high-performance sealing solutions. Advanced materials and manufacturing technologies contribute to the market’s positive outlook over the forecast period.

Segment Analysis

The global injection port market is dominated by the plastics sub-segment, which holds around 70% market share. Plastics are extensively used as injection ports in pharmaceutical and biopharmaceutical industries as they can withstand high pressure and temperature during production processes. Plastics are cost-effective and easy to manufacture when compared to metals, hence boosting their adoption.

PEST Analysis

Political: Regulations around pharmaceutical and biopharmaceutical production have become stringent over the years, driving the need for quality injection ports.

Economic: Increasing healthcare expenditure globally is positively impacting the injection port market. Further, investments in R&D of new drugs and therapeutics are fueling market growth.

Social: Rising prevalence of chronic diseases is triggering higher demand for medicines. This is augmenting consumption of injection ports in pharmaceutical manufacturing.

Technological: Advances in material science have facilitated development of innovative injection port materials with superior properties. 3D printing technology is also gaining attention in customized injection port fabrication.

Key Takeaways

The Global Injection Port Market Demand is expected to witness high growth over the forecast period of 2024 to 2031. The market size for 2024 is estimated to be US$ 1.57 Bn.

Regional analysis

North America dominates the global injection port market currently due to strong pharmaceutical sector and rising research activities in the region. The Asia Pacific region is anticipated to be the fastest growing market owing to increasing healthcare spending, emerging biopharma industry, and supportive government policies.

Key players

Key players operating in the injection port market are Jungbunzlauer, G.E. Healthcare, Gerresheimer, Medtronic, SMS, and SCHOTT. Jungbunzlauer offers wide variety of injection ports under the trade name Simriz used in pharmaceutical filling. G.E. Healthcare provides injection ports made from ceramics for high-pressure and corrosive applications.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it